TVGN:NASDAQTevogen Bio Holdings Inc. Analysis
Data as of 2026-08-31 - not real-time
$6.80
Latest Price
9/10Risk
Risk Level: High
Executive Summary
At $6.80, Tevogen Bio Holdings Inc. shows no decisive moving-average alignment, leaving the trend neutral. Across the trailing 30 sessions it gained 74.8%. With RSI at 54.7 the momentum picture is neutral, alongside a bullish MACD signal. Watch $5.90 as support and $7.09 as the nearer resistance level.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 84.1%, a beta of 2.04 and a maximum drawdown of 91.3%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 84.1%, a beta of 2.04 and a maximum drawdown of 91.3%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.
Top Market Events
TEVOGEN Tevogen Initiatives WARREN, N.J., July 13, 2026 GLOBE NEWSWIRE -- Tevogen “Tevogen Bio Holdings Inc.” or...Tevogen Bio Holdings Inc. Becomes Tevogen Inc.Yahoo Finance1monTevogen Bio Holdings Inc.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 10.96
- MACD momentum is positive
- 30-day price change of +74.8%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 10.96
- 30-day volatility of 84.1%
- MACD momentum is positive
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- Negative free cash flow
- 30-day volatility of 84.1%
- Beta of 2.04 versus the benchmark
Key Metrics & Analysis
Financial Health
ROA-297.37%
P/B Ratio-1.5
Op. Cash Flow$-11569983
Free Cash Flow$-3051937
Industry P/E30.3
Technical Analysis
TrendNeutral
RSI54.7
Support$5.90
Resistance$7.09
MA 20$6.66
MA 50$6.24
MA 200$10.96
MACDBullish
VolumeDecreasing
Fear & Greed Index94.27
Valuation
GradeFair
TypeBlend
Risk Assessment
Beta2.04
Volatility84.07%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.